Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803) †
Titel:
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803) †
Auteur:
Wu, Y.-L. Zhou, C. Cheng, Y. Lu, S. Chen, G.-Y. Huang, C. Huang, Y.-S. Yan, H.-H. Ren, S. Liu, Y. Yang, J.-J.